| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immuneering Corp (IMRX) has 13 insiders with recent SEC Form 4 filings, including 9 buys and 5 sells. IMRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 688.0K | $3.59M | - | |
| Other | 344.0K | $1.80M | - | |
| Other | 176.0K | $918.7K | - | |
| Other | 140.0K | $730.8K | - | |
| Other | 140.0K | $730.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Cormorant Asset Management, LP50 | - | Sell | 909,091 | $3.02 | $2,749,003.29 | -4.7% | -11.5% | -16.2% | |
| May 25, 2022 | Hall Brett Matthew53 | Chief Scientific Officer | Buy | 2,551 | $3.92 | $9,999.92 | +0.8% | +62.7% | +67.9% | |
| May 17, 2022 | Bookman Michael49 | General Counsel And Secretary | Buy | 1,000 | $4.88 | $4,880.00 | +71.3% | +30.6% | +71.1% | |
| May 16, 2022 | Keating Laurie55 | Director | Buy | 7,000 | $5.00 | $35,000.00 | +100.0% | +40.9% | +79.3% | |
| May 12, 2022 | Amin Biren | CFO, Treasurer | Buy | 1,000 | $4.42 | $4,420.00 | +14.5% | +31.9% | +54.1% | |
| Mar 23, 2022 | Zeskind Benjamin J.46 | President And CEO | Buy | 3,000 | $8.02 | $24,060.00 | +0.1% | -39.4% | +35.9% | |
| Mar 23, 2022 | Hall Brett Matthew53 | Chief Scientific Officer | Buy | 1,050 | $7.91 | $8,305.50 | +0.3% | -39.4% | +35.9% | |
| Mar 22, 2022 | Barrett Scott | Chief Medical Officer | Buy | 900 | $7.49 | $6,736.50 | +13.5% | -42.1% | +28.2% | |
| Mar 15, 2022 | Berman Ann E | Director | Buy | 6,000 | $6.40 | $38,400.00 | +171.4% | -28.7% | +18.4% | |
| Mar 15, 2022 | Feinberg Peter | Director | Buy | 6,667 | $6.75 | $45,002.25 | +130.8% | -28.7% | +18.4% |